Marvel Biosciences Corp. (TSXV:MRVL)
0.0850
+0.0050 (6.25%)
May 16, 2025, 2:36 PM EDT
Marvel Biosciences Statistics
Total Valuation
TSXV:MRVL has a market cap or net worth of CAD 3.81 million. The enterprise value is 5.46 million.
Market Cap | 3.81M |
Enterprise Value | 5.46M |
Important Dates
The next estimated earnings date is Wednesday, June 18, 2025.
Earnings Date | Jun 18, 2025 |
Ex-Dividend Date | n/a |
Share Statistics
TSXV:MRVL has 44.80 million shares outstanding. The number of shares has increased by 6.74% in one year.
Current Share Class | 44.80M |
Shares Outstanding | 44.80M |
Shares Change (YoY) | +6.74% |
Shares Change (QoQ) | +0.01% |
Owned by Insiders (%) | 16.29% |
Owned by Institutions (%) | 12.26% |
Float | 36.65M |
Valuation Ratios
PE Ratio | n/a |
Forward PE | n/a |
PS Ratio | n/a |
PB Ratio | -1.07 |
P/TBV Ratio | n/a |
P/FCF Ratio | n/a |
P/OCF Ratio | n/a |
PEG Ratio | n/a |
Enterprise Valuation
EV / Earnings | -3.28 |
EV / Sales | n/a |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | n/a |
Financial Position
The company has a current ratio of 0.11
Current Ratio | 0.11 |
Quick Ratio | 0.09 |
Debt / Equity | n/a |
Debt / EBITDA | n/a |
Debt / FCF | n/a |
Interest Coverage | -7.97 |
Financial Efficiency
Return on Equity (ROE) | n/a |
Return on Assets (ROA) | -176.11% |
Return on Invested Capital (ROIC) | n/a |
Return on Capital Employed (ROCE) | 71.35% |
Revenue Per Employee | n/a |
Profits Per Employee | n/a |
Employee Count | n/a |
Asset Turnover | n/a |
Inventory Turnover | n/a |
Taxes
Income Tax | n/a |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -15.00% in the last 52 weeks. The beta is 0.67, so TSXV:MRVL's price volatility has been lower than the market average.
Beta (5Y) | 0.67 |
52-Week Price Change | -15.00% |
50-Day Moving Average | 0.11 |
200-Day Moving Average | 0.13 |
Relative Strength Index (RSI) | 38.10 |
Average Volume (20 Days) | 29,525 |
Short Selling Information
Short Interest | n/a |
Short Previous Month | n/a |
Short % of Shares Out | n/a |
Short % of Float | n/a |
Short Ratio (days to cover) | n/a |
Income Statement
Revenue | n/a |
Gross Profit | n/a |
Operating Income | -1.31M |
Pretax Income | -1.66M |
Net Income | -1.66M |
EBITDA | n/a |
EBIT | -1.31M |
Earnings Per Share (EPS) | -0.04 |
Balance Sheet
The company has 59,530 in cash and 1.71 million in debt, giving a net cash position of -1.65 million or -0.04 per share.
Cash & Cash Equivalents | 59,530 |
Total Debt | 1.71M |
Net Cash | -1.65M |
Net Cash Per Share | -0.04 |
Equity (Book Value) | -3.55M |
Book Value Per Share | -0.08 |
Working Capital | -1.84M |
Cash Flow
Operating Cash Flow | -989,409 |
Capital Expenditures | n/a |
Free Cash Flow | n/a |
FCF Per Share | n/a |
Margins
Gross Margin | n/a |
Operating Margin | n/a |
Pretax Margin | n/a |
Profit Margin | n/a |
EBITDA Margin | n/a |
EBIT Margin | n/a |
FCF Margin | n/a |
Dividends & Yields
TSXV:MRVL does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | -6.74% |
Shareholder Yield | -6.74% |
Earnings Yield | -43.66% |
FCF Yield | n/a |
Stock Splits
This stock does not have any record of stock splits.
Last Split Date | n/a |
Split Type | n/a |
Split Ratio | n/a |
Scores
Altman Z-Score | n/a |
Piotroski F-Score | n/a |